| UNITED      STATESSECURITIES      AND EXCHANGE COMMISSIONWashington,      D.C.  20549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  FORM      10-Q                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| x QUARTERLY REPORT PURSUANT      TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|  For      the Quarterly Period Ended January 31, 2009 OR ¨ TRANSITION REPORT      PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF      1934 For      the transition period from ___________ to ___________ Commission      file number 1-5865                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Gerber      Scientific, Inc.(Exact      name of registrant as specified in its charter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Connecticut                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 06-0640743 |
| (State      or other jurisdiction of incorporation or organization)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | (I.R.S.      Employer Identification No.) |
| 83      Gerber Road West, South Windsor, Connecticut(Address      of principal executive offices)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 06074(Zip      Code) |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Registrant's      telephone number, including area code:  (860)      644-1551                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Indicate      by check mark whether the registrant (1) has filed all reports required to      be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934      during the preceding 12 months (or for such shorter period that the      registrant was required to file such reports), and (2) has been subject to      such filing requirements for the past 90 days.  Yes x    No      ¨                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Indicate      by check mark whether the registrant is a large accelerated filer, an      accelerated filer, a non-accelerated filer, or a smaller reporting      company.  See the definitions of “large accelerated filer,”      “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the      Exchange Act.Large      accelerated filer ¨                                                                                     Accelerated      filer x                               Non-accelerated      filer  ¨      (Do not check if a smaller reporting      company)       Smaller reporting      company   ¨ |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Indicate      by check mark whether the registrant is a shell company (as defined in      Rule 12b-2 of the Exchange Act).Yes      ¨    No      x                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 24,129,529      shares of common stock of the registrant were outstanding as of February      28, 2009, exclusive of treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |   |   |

----

|               | GERBER      SCIENTIFIC, INC.Index      to Quarterly Reporton      Form 10-QFiscal      Quarter Ended January 31, 2009 |   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------|--------|
| PART      I        | PAGE                                                                                                                  |
|               |                                                                                                                  |   |
| Item      1.       | Financial      Statements                                                                                             |   |
|               | Condensed      Consolidated Statements of Operations                                                                  | 3-4    |
|               | Condensed      Consolidated Balance Sheets                                                                            | 5      |
|               | Condensed      Consolidated Statements of Cash Flows                                                                  | 6      |
|               | Notes      to Condensed Consolidated Financial Statements                                                             | 7-16   |
| Item      2        | Management's      Discussion and Analysis of Financial Condition and Results of      Operations                       | 17-29  |
| Item      3.       | Quantitative      and Qualitative Disclosures about Market Risk                                                       | 29     |
| Item      4.       | Controls      and Procedures                                                                                          | 29-30  |
|               |                                                                                                                  |   |
| PART      II       |                                                                                                                  |
|               |                                                                                                                  |   |
| Item      1A.      | Risk      Factors                                                                                                     | 31     |
| Item      2.       | Unregistered      Sales of Equity Securities and Use of Proceeds                                                      | 31     |
| Item      5.       | Other      Information                                                                                                | 31-32  |
| Item      6.       | Exhibits                                                                                                              | 32     |
|               |                                                                                                                  |   |
| Signature          | 33                                                                                                                    |
| Exhibit      Index | 34                                                                                                                    |

----

|                                                     | For      the Fiscal Quarters Ended January 31, |   |
|----------------------------------------------------------|------------------------------------------------|--------|
| In      thousands, except per share data                 |                                           | 2009   |   |   | 2008 |   |
| Revenue:                                                 |                                           |   |   |   |   |   |
|      Product      sales         |                                           | $      | 102,513 |   |   | $ | 133,637 |   |
|      Service      sales         |                                           |   | 17,584 |   |   |   | 18,329 |   |
|                                                     |                                           |   | 120,097 |   |   |   | 151,966 |   |
| Cost      of Sales:                                      |                                           |   |   |   |   |   |   |   |
|      Cost      of products sold |                                           |   | 74,042 |   |   |   | 95,428 |   |
|      Cost      of services sold |                                           |   | 10,536 |   |   |   | 13,085 |   |
|                                                     |                                           |   | 84,578 |   |   |   | 108,513 |   |
|                                                     |                                           |   |   |   |   |   |   |   |
| Gross      profit                                        |                                           |   | 35,519 |   |   |   | 43,453 |   |
|                                                     |                                           |   |   |   |   |   |   |   |
| Selling,      general and administrative expenses        |                                           |   | 30,193 |   |   |   | 30,691 |   |
| Research      and development                            |                                           |   | 5,329 |   |   |   | 6,466 |   |
| Operating      (loss) income                             |                                           |   | (3 | ) |   |   | 6,296 |   |
|                                                     |                                           |   |   |   |   |   |   |   |
| Other      income (expense), net                         |                                           |   | (2,993 | ) |   |   | (435 | ) |
| Interest      expense                                    |                                           |   | (877 | ) |   |   | (1,388 | ) |
| (Loss)      Income before income taxes                   |                                           |   | (3,873 | ) |   |   | 4,473 |   |
| Income      tax (benefit) expense                        |                                           |   | (1,641 | ) |   |   | 1,410 |   |
| Net      (loss) income                                   |                                           | $      | (2,232 | ) |   | $ | 3,063 |   |
| (Loss)      Earnings Per Share of Common Stock:          |                                           |   |   |   |   |   |   |   |
|   Basic                                        |                                           | $      | (0.09 | ) |   | $ | 0.13 |   |
|   Diluted                                      |                                           | $      | (0.09 | ) |   | $ | 0.13 |   |
| Weighted      Average Shares Outstanding:                |                                           |   |   |   |   |   |   |   |
|   Basic                                        |                                           |   | 23,602 |   |   |   | 23,374 |   |
|   Diluted                                      |                                           |   | 23,602 |   |   |   | 23,618 |   |

----

|                                                     | For      the Nine Months Ended January 31, |   |
|----------------------------------------------------------|--------------------------------------------|--------|
| In      thousands, except per share data                 |                                       | 2009   |   |   | 2008 |   |
| Revenue:                                                 |                                       |   |   |   |   |   |
|      Product      sales         |                                       | $      | 377,114 |   |   | $ | 411,022 |   |
|      Service      sales         |                                       |   | 55,599 |   |   |   | 55,327 |   |
|                                                     |                                       |   | 432,713 |   |   |   | 466,349 |   |
| Cost      of Sales:                                      |                                       |   |   |   |   |   |   |   |
|      Cost      of products sold |                                       |   | 275,251 |   |   |   | 294,302 |   |
|      Cost      of services sold |                                       |   | 36,305 |   |   |   | 36,737 |   |
|                                                     |                                       |   | 311,556 |   |   |   | 331,039 |   |
|                                                     |                                       |   |   |   |   |   |   |   |
| Gross      profit                                        |                                       |   | 121,157 |   |   |   | 135,310 |   |
|                                                     |                                       |   |   |   |   |   |   |   |
| Selling,      general and administrative expenses        |                                       |   | 96,295 |   |   |   | 99,022 |   |
| Research      and development                            |                                       |   | 17,331 |   |   |   | 19,483 |   |
| Operating      income                                    |                                       |   | 7,531 |   |   |   | 16,805 |   |
|                                                     |                                       |   |   |   |   |   |   |   |
| Other      income (expense), net                         |                                       |   | (4,058 | ) |   |   | (1,046 | ) |
| Interest      expense                                    |                                       |   | (2,354 | ) |   |   | (3,460 | ) |
| Income      before income taxes                          |                                       |   | 1,119 |   |   |   | 12,299 |   |
| Income      tax (benefit) expense                        |                                       |   | (3,424 | ) |   |   | 3,898 |   |
| Net      income                                          |                                       | $      | 4,543 |   |   | $ | 8,401 |   |
| Earnings      Per Share of Common Stock:                 |                                       |   |   |   |   |   |   |   |
|   Basic                                        |                                       | $      | 0.19 |   |   | $ | 0.36 |   |
|   Diluted                                      |                                       | $      | 0.19 |   |   | $ | 0.36 |   |
| Weighted      Average Shares Outstanding:                |                                       |   |   |   |   |   |   |   |
|   Basic                                        |                                       |   | 23,539 |   |   |   | 23,296 |   |
|   Diluted                                      |                                       |   | 23,657 |   |   |   | 23,600 |   |

----

|                                                                             |   | January      31, |    |   | April      30, |   |
|----------------------------------------------------------------------------------|--------|------------------|---------|--------|----------------|--------|
| In      thousands                                                                |   | 2009             |    |   | 2008           |   |
| Assets:                                                                          |   |             |    |   |           |   |
| Current      Assets:                                                             |   |             |    |   |           |   |
|      Cash      and cash equivalents                     |   | $                | 10,940  |   |           | $      | 13,892 |   |
|      Accounts      receivable, net                      |   |             | 83,339  |   |           |   | 120,752 |   |
|      Inventories                                        |   |             | 79,276  |   |           |   | 76,927 |   |
|      Deferred      tax assets                           |   |             | 7,029   |   |           |   | 7,600 |   |
|      Prepaid      expenses and other current assets     |   |             | 5,257   |   |           |   | 5,829 |   |
|         Total      Current Assets        |   |             | 185,841 |   |           |   | 225,000 |   |
| Property,      plant and equipment, net                                          |   |             | 37,472  |   |           |   | 39,852 |   |
| Goodwill                                                                         |   |             | 75,334  |   |           |   | 61,844 |   |
| Deferred      tax assets                                                         |   |             | 41,812  |   |           |   | 34,354 |   |
| Other      assets                                                                |   |             | 18,370  |   |           |   | 17,489 |   |
| Total      Assets                                                                |   | $                | 358,829 |   |           | $      | 378,539 |   |
| Liabilities      and Shareholders' Equity:                                       |   |             |    |   |           |   |   |   |
| Current      Liabilities:                                                        |   |             |    |   |           |   |   |   |
|      Accounts      payable                              |   | $                | 40,355  |   |           | $      | 51,253 |   |
|      Accrued      compensation and benefits             |   |             | 15,354  |   |           |   | 23,671 |   |
|      Other      accrued liabilities                     |   |             | 24,346  |   |           |   | 27,672 |   |
|      Deferred      revenue                              |   |             | 13,726  |   |           |   | 16,399 |   |
|         Total      Current Liabilities   |   |             | 93,781  |   |           |   | 118,995 |   |
| Long-term      debt                                                              |   |             | 75,000  |   |           |   | 42,000 |   |
| Accrued      pension benefit liability                                           |   |             | 25,233  |   |           |   | 28,514 |   |
| Other      long-term liabilities                                                 |   |             | 18,053  |   |           |   | 19,467 |   |
|                                                                             |   |             |    |   |           |   |   |   |
| Commitments      and contingencies                                               |   |             |    |   |           |   |   |   |
|  Shareholders'      Equity:                                                 |   |             |    |   |           |   |   |   |
|      Preferred      stock                               |   |             | ---     |   |           |   | --- |   |
|      Common      stock                                  |   |             | 247     |   |           |   | 243 |   |
|      Paid-in      capital                               |   |             | 78,528  |   |           |   | 75,472 |   |
|      Retained      earnings                             |   |             | 99,969  |   |           |   | 95,426 |   |
|      Treasury      stock                                |   |             | (11,686 | )      |           |   | (12,148 | ) |
|      Accumulated      other comprehensive (loss) income |   |             | (20,296 | )      |           |   | 10,570 |   |
|         Total      Shareholders' Equity  |   |             | 146,762 |   |           |   | 169,563 |   |
| Total      Liabilities and Shareholders' Equity                                  |   | $                | 358,829 |   |           | $      | 378,539 |   |

----

|                                                                                                                        | For      the Nine Months Ended January 31, |   |
|-----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|--------|
| In      thousands                                                                                                           |                                       | 2009   |   |   | 2008 |   |
| Cash      flows from operating activities:                                                                                  |                                       |   |   |   |   |   |
| Net      income                                                                                                             |                                       | $      | 4,543 |   |   | $ | 8,401 |   |
| Adjustments      to reconcile net income to cash provided by   (used      for) operating activities:    |                                       |   |   |   |   |   |   |   |
|        Depreciation      and amortization                                                |                                       |   | 7,547 |   |   |   | 7,005 |   |
|        Deferred      income taxes                                                        |                                       |   | (5,173 | )  |   |   | 799 |   |
|        Stock-based      compensation                                                     |                                       |   | 2,428 |   |   |   | 1,200 |   |
|        Gain      on sale of assets                                                       |                                       |   | (622 | ) |   |   | (950 | ) |
|        Other-than-temporary      impairment charge                                       |                                       |   | 2,290 |   |   |   | --- |   |
|        Other      noncash items                                                          |                                       |   | 977 |   |   |   | 1,685 |   |
|        Changes      in operating accounts, excluding effects of acquisitions:            |                                       |   |   |   |   |   |   |   |
|             Accounts      receivable                            |                                       |   | 27,929 |   |   |   | 8,448 |   |
|             Inventories                                         |                                       |   | (3,166 | ) |   |   | (7,994 | ) |
|             Prepaid      expenses and other assets              |                                       |   | (114 | ) |   |   | 266 |   |
|             Accounts      payable and other accrued liabilities |                                       |   | (21,577 | ) |   |   | (14,750 | ) |
|             Accrued      compensation and benefits              |                                       |   | (8,744 | ) |   |   | (5,478 | ) |
| Net      cash provided by (used for) operating activities                                                                   |                                       |   | 6,318 |   |   |   | (1,368 | ) |
| Cash      flows from investing activities:                                                                                  |                                       |   |   |   |   |   |   |   |
|    Capital      expenditures                                                                                 |                                       |   | (6,471 | ) |   |   | (6,405 | ) |
|    Proceeds      from sale of assets                                                                         |                                       |   | 2,590 |   |   |   | 150 |   |
|    Proceeds      from sale of available for sale investments                                                 |                                       |   | 705 |   |   |   | 571 |   |
|    Purchases      of available for sale investments                                                          |                                       |   | (432 | ) |   |   | (605 | ) |
|    Business      acquisitions                                                                                |                                       |   | (34,273 | ) |   |   | (4,650 | ) |
|    Acquisition      of intangible assets                                                                     |                                       |   | (678 | ) |   |   | (392 | ) |
| Net      cash used for investing activities                                                                                 |                                       |   | (38,559 | ) |   |   | (11,331 | ) |
| Cash      flows from financing activities:                                                                                  |                                       |   |   |   |   |   |   |   |
|    Debt      repayments                                                                                      |                                       |   | (56,771 | ) |   |   | (297,256 | ) |
|    Debt      proceeds                                                                                        |                                       |   | 88,500 |   |   |   | 312,809 |   |
|    Debt      issuance costs                                                                                  |                                       |   | --- |   |   |   | (942 | ) |
|    Common      stock issued                                                                                  |                                       |   | 899 |   |   |   | 1,446 |   |
| Net      cash provided by financing activities                                                                              |                                       |   | 32,628 |   |   |   | 16,057 |   |
| Effect      of exchange rate changes on cash                                                                                |                                       |   | (3,339 | ) |   |   | 889 |   |
| (Decrease)      Increase in cash and cash equivalents                                                                       |                                       |   | (2,952 | ) |   |   | 4,247 |   |
| Cash      and cash equivalents at beginning of period                                                                       |                                       |   | 13,892 |   |   |   | 8,052 |   |
| Cash      and cash equivalents at end of period                                                                             |                                       | $      | 10,940 |   |   | $ | 12,299 |   |

----

----

|                                                                   |   | January      31, |   |   | April      30, |   |
|------------------------------------------------------------------------|--------|------------------|--------|--------|----------------|--------|
| In      thousands                                                      |   | 2009             |   |   | 2008           |   |
| Raw      materials and purchased parts                                 |   | $                | 65,182 |   |           | $      | 64,230 |   |
| Work      in process                                                   |   |             | 6,174  |   |           |   | 2,894 |   |
| Finished      goods                                                    |   |             | 7,920  |   |           |   | 9,803 |   |
|         Total      inventories |   | $                | 79,276 |   |           | $      | 76,927 |   |

----

|  In      thousands                                      |   | October      21, 2008 |   |
|--------------------------------------------------------------|--------|-----------------------|--------|
| Assets      acquired:                                        |   |                  |   |
| Cash      and cash equivalents                               |   | $                     | 4,128  |   |
| Accounts      receivable                                     |   |                  | 7,190  |   |
| Inventories                                                  |   |                  | 8,524  |   |
| Prepaid      and other assets                                |   |                  | 655    |   |
| Property,      plant and equipment                           |   |                  | 1,985  |   |
| Goodwill                                                     |   |                  | 16,127 |   |
| Deferred      tax assets                                     |   |                  | 619    |   |
| Other      assets                                            |   |                  | 5,124  |   |
|      Total      assets acquired     |   | $                     | 44,352 |   |
| Liabilities      assumed:                                    |   |                  |   |   |
| Accounts      payable                                        |   |                  | 3,090  |   |
| Accrued      compensation and benefits                       |   |                  | 2,848  |   |
| Other      liabilities                                       |   |                  | 5,043  |   |
| Deferred      revenue                                        |   |                  | 918    |   |
|      Total      liabilities assumed |   | $                     | 11,899 |   |
| Net      assets acquired                                     |   | $                     | 32,453 |   |

|                                                                                   |   | January      31, 2009 |   |   | April      30, 2008     |   |
|----------------------------------------------------------------------------------------|--------|-----------------------|--------|--------|-------------------------|--------|
|   In      thousands                                                          |   | GrossCarryingAmount   |   |   | AccumulatedAmortization |   |   | GrossCarryingAmount |   |   | AccumulatedAmortization |   |
| Amortized      intangible assets:                                                      |   |                  |   |   |                    |   |   |   |   |   |   |   |
|    Patents                                                              |   | $                     | 7,483  |   |                    | $      | 3,036 |   |   | $ | 7,512 |   |   | $ | 3,062 |   |
|    Other                                                                |   |                  | 6,983  |   |                    |   | 688 |   |   |   | 646 |   |   |   | 413 |   |
|         Total      amortized intangible assets |   | $                     | 14,466 |   |                    | $      | 3,724 |   |   | $ | 8,158 |   |   | $ | 3,475 |   |

----

|   In      thousands                   |   | Sign      Making and      Specialty Graphics |   |   | Apparel      andFlexibleMaterials |   |   | OphthalmicLensProcessing |   |   | Total  |   |
|-------------------------------------------------|--------|--------------------------------------------------------|--------|--------|-----------------------------------|--------|--------|--------------------------|--------|--------|--------|--------|
| Balance      as of April 30, 2008               |   | $                                                      | 30,699 |   |                              | $      | 14,149 |                     |   | $      | 16,996 |   |   | $ | 61,844 |   |
| Business      acquisitions                      |   |                                                   | ---    |   |                              |   | 19,978 |                     |   |   | ---    |   |   |   | 19,978 |   |
| Adjustment      to previously reported goodwill |   |                                                   | 92     |   |                              |   | ---    |                     |   |   | ---    |   |   |   | 92 |   |
| Effects      of currency translation            |   |                                                   | (5,990 | )      |                              |   | (590   | )                        |   |   | --     |   |   |   | (6,580 | ) |
| Balance      as of January 31, 2009             |   | $                                                      | 24,801 |   |                              | $      | 33,537 |                     |   | $      | 16,996 |   |   | $ | 75,334 |   |

|                                                                                                  |   | For      the Fiscal QuartersEnded      January 31, |    |   | For      the Nine MonthsEnded      January 31, |   |
|-------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------|---------|--------|------------------------------------------------|--------|
| In      thousands                                                                                     |   | 2009                                               |    |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Sign      Making and Specialty Graphics:                                                              |   |                                               |    |   |                                           |   |   |   |   |   |   |   |
|   Gerber      Scientific Products                                                           |   | $                                                  | 18,512  |   |                                           | $      | 23,237 |   |   | $ | 70,729 |   |   | $ | 75,018 |   |
|   Spandex                                                                                   |   |                                               | 46,190  |   |                                           |   | 60,758 |   |   |   | 180,532 |   |   |   | 185,612 |   |
| Sign      Making and Specialty Graphics                                                               |   |                                               | 64,702  |   |                                           |   | 83,995 |   |   |   | 251,261 |   |   |   | 260,630 |   |
| Apparel      and Flexible Materials                                                                   |   |                                               | 43,009  |   |                                           |   | 52,146 |   |   |   | 137,890 |   |   |   | 153,065 |   |
| Ophthalmic      Lens Processing                                                                       |   |                                               | 12,386  |   |                                           |   | 15,825 |   |   |   | 43,562 |   |   |   | 52,654 |   |
|           Consolidated      revenue                 |   | $                                                  | 120,097 |   |                                           | $      | 151,966 |   |   | $  | 432,713 |   |   | $  | 466,349 |   |
|                                                                                                  |   |                                               |    |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
| Sign      Making and Specialty Graphics:                                                              |   |                                               |    |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|   Gerber      Scientific Products                                                           |   | $                                                  | 389     |   |                                           | $      | (502 | ) |   | $ | (234 | ) |   | $ | (71 | ) |
|   Spandex                                                                                   |   |                                               | 516     |   |                                           |   | 2,589 |   |   |   | 6,432 |   |   |   | 6,610 |   |
| Sign      Making and Specialty Graphics                                                               |   |                                               | 905     |   |                                           |   | 2,087 |   |   |   | 6,198 |   |   |   | 6,539 |   |
| Apparel      and Flexible Materials                                                                   |   |                                               | 2,691   |   |                                           |   | 5,645 |   |   |   | 11,340 |   |   |   | 19,129 |   |
| Ophthalmic      Lens Processing                                                                       |   |                                               | 737     |   |                                           |   | (340 | ) |   |   | 2,625 |   |   |   | 3,039 |   |
|         Segment      operating income                         |   |                                               | 4,333   |   |                                           |   | 7,392 |   |   |   | 20,163 |   |   |   | 28,707 |   |
| Corporate      operating expenses                                                                     |   |                                               | (4,336  | )      |                                           |   | (1,096 | ) |   |   | (12,632 | ) |   |   | (11,902 | ) |
|           Consolidated      operating (loss) income |   | $                                                  | (3      | )      |                                           | $      | 6,296 |   |   | $ | 7,531 |   |   | $ | 16,805 |   |

----

|                                                                            |   | For      the Fiscal QuartersEnded      January 31, |   |   | For      the Nine MonthsEnded      January 31, |   |
|---------------------------------------------------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands                                                               |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Net      (loss) income                                                          |   | $                                                  | (2,232 | )      |                                           | $      | 3,063 |   |   | $ | 4,543 |   |   | $ | 8,401 |   |
|                                                                            |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
| Other      comprehensive (loss) income:                                         |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|     Foreign      currency translation adjustments           |   |                                               | (3,677 | )      |                                           |   | (1,098 | ) |   |   | (31,266 | ) |   |   | 7,441 |   |
|     Defined      benefit pension plans activity, net of tax |   |                                               | 205    |   |                                           |   | 143 |   |   |   | 614 |   |   |   | 428 |   |
|     Unrealized      investment income (loss), net of tax    |   |                                               | 1,283  |   |                                           |   | (403 | ) |   |   | 474 |   |   |   | (412 | ) |
|     Net      loss on derivative instruments, net of tax     |   |                                               | (561   | )      |                                           |   | --- |   |   |   | (688 | ) |   |   | --- |   |
| Total      comprehensive (loss) income                                          |   | $                                                  | (4,982 | )      |                                           | $      | 1,705 |   |   | $  | (26,323 | ) |   | $  | 15,858 |   |

|                                              |   | For      the Fiscal Quarters Ended January 31, |   |
|---------------------------------------------------|--------|------------------------------------------------|--------|
|                                              |   | 2009                                           |   |   | 2008 |   |
|  In      thousands, except per share amounts |   | NetLoss                                        |   |   | AverageShares |   |   | PerShare |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |
| Basic      (loss) earnings per share              |   | $                                              | (2,232 | ) |   |   | 23,602 |   |   | $ | (0.09 | ) |   | $ | 3,063 |   |   |   | 23,374 |   |   | $ | 0.13 |   |
| Effect      of dilutive options and awards        |   |                                           | ---    |   |   |   | --- |   |   |   | --- |   |   |   | --- |   |   |   | 244 |   |   |   | --- |   |
| Diluted      (loss) earnings per share            |   | $                                              | (2,232 | ) |   |   | 23,602 |   |   | $ | (0.09 | ) |   | $ | 3,063 |   |   |   | 23,618 |   |   | $ | 0.13 |   |

|                                              |   | For      the Nine Months Ended January 31, |   |
|---------------------------------------------------|--------|--------------------------------------------|--------|
|                                              |   | 2009                                       |   |   | 2008 |   |
|  In      thousands, except per share amounts |   | NetIncome                                  |   |   | AverageShares |   |   | PerShare |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |
| Basic      earnings per share                     |   | $                                          | 4,543  |   |   |   | 23,539 |   |   | $ | 0.19 |   |   | $ | 8,401 |   |   |   | 23,296 |   |   | $ | 0.36 |   |
| Effect      of dilutive options and awards        |   |                                       | ---    |   |   |   | 118 |   |   |   | --- |   |   |   | --- |   |   |   | 304 |   |   |   | --- |   |
| Diluted      earnings per share                   |   | $                                          | 4,543  |   |   |   | 23,657 |   |   | $ | 0.19 |   |   | $ | 8,401 |   |   |   | 23,600 |   |   | $ | 0.36 |   |

----

|                                         | For      the Nine Months Ended January 31, |   |
|----------------------------------------------|--------------------------------------------|--------|
| In      thousands                            |                                       | 2009   |   |   | 2008 |   |
| Beginning      balance                       |                                       | $      | 2,327 |   |   | $ | 2,337 |   |
| Warranties      issued in the current period |                                       |   | 3,738 |   |   |   | 4,771 |   |
| Impact      of business acquisitions         |                                       |   | 668 |   |   |   | --- |   |
| Reductions      for costs incurred           |                                       |   | (3,984 | ) |   |   | (4,701 | ) |
| Ending      balance                          |                                       | $      | 2,749 |   |   | $ | 2,407 |   |

|                                      |   | For      the Fiscal QuartersEnded      January 31, |   |   | For      the Nine MonthsEnded      January 31, |   |
|-------------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands                         |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Service      cost                         |   | $                                                  | 597    |   |                                           | $      | 647 |   |   | $ | 1,791 |   |   | $ | 1,941 |   |
| Interest      cost                        |   |                                               | 1,770  |   |                                           |   | 1,615 |   |   |   | 5,310 |   |   |   | 4,845 |   |
| Expected      return on plan assets       |   |                                               | (1,709 | )      |                                           |   | (1,760 | ) |   |   | (5,129 | ) |   |   | (5,280 | ) |
| Amortization      of:                     |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|    Prior      service cost |   |                                               | 73     |   |                                           |   | 73 |   |   |   | 219 |   |   |   | 219 |   |
|    Actuarial      loss     |   |                                               | 253    |   |                                           |   | 154 |   |   |   | 759 |   |   |   | 462 |   |
| Net      periodic benefit cost            |   | $                                                  | 984    |   |                                           | $      | 729 |   |   | $ | 2,950 |   |   | $ | 2,187 |   |

----

| Level 2 |           Quoted prices for similar assets or liabilities in active markets or      inputs that are observable for the asset or liability, either directly or      indirectly through market corroboration,for substantially the full term of      the financial instrument. |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   In      thousands       |   | Total  |   |    | Quotedprices      inactivemarkets(Level      1) |   | Significantotherobservableinputs(Level      2) |   |   | Significantunobservableinputs(Level      3) |   |
|-------------------------------------|--------|--------|--------|---------|-------------------------------------------------|--------|------------------------------------------------|--------|--------|---------------------------------------------|--------|
| Interest      rate swap agreement   |   | $      | (1,097 | )  |                                            | $      | ---                                            |   |   | $                                           | (1,097 | )  |   | $ | --- |   |
| Available      for sale investments |   |   | 2,766  |    |                                            |   | 2,766                                          |   |   |                                        | ---    |   |   |   | --- |   |
|     Total       |   | $      | 1,669  |    |                                            | $      | 2,766                                          |   |   | $                                           | (1,097 | ) |   | $ | --- |   |

----

----

| Total      Funded Debt to Consolidated EBITDA Ratio |   | ABR      Margin(basis      points) |   |   | LIBOR      Margin(basis      points) |   |   | Commitment      Fee (basis points) |   |
|-----------------------------------------------------|--------|------------------------------------|--------|--------|--------------------------------------|--------|--------|------------------------------------|--------|
| 3.00x      and greater                              |   |                               | 300.0  |   |                                 |   | 400.0  |                               |   |   | 50.0 |   |
| 2.25x      to less than 3.00x                       |   |                               | 225.0  |   |                                 |   | 325.0  |                               |   |   | 50.0 |   |
| 1.50x      to less than 2.25x                       |   |                               | 175.0  |   |                                 |   | 275.0  |                               |   |   | 37.5 |   |
| 0.75x      to less than 1.50x                       |   |                               | 137.5  |   |                                 |   | 237.5  |                               |   |   | 25.0 |   |
| Less      than 0.75x                                |   |                               | 100.0  |   |                                 |   | 200.0  |                               |   |   | 25.0 |   |

----

----

| ·   | expected      financial condition, future earnings, levels of growth, or other measures      of financial performance, or the future size of market segments or      geographic markets; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | economic      conditions; |
|--------------------|---------------------------|

| ·   | planned      cost reductions; |
|--------------------|-------------------------------|

| ·   | future      cash flows and uses of cash and debt reduction  strategies; |
|--------------------|-------------------------------------------------------------------------|

| ·   | prospective      product development and business growth opportunities, as well as      competitor product developments; |
|--------------------|--------------------------------------------------------------------------------------------------------------------------|

| ·   | demand      for the Company's products andservices; |
|--------------------|-----------------------------------------------------|

| ·   | methods      of and costs associated with potential geographic    expansion; |
|--------------------|------------------------------------------------------------------------------|

| ·   | regulatory      and market developments and the impact of such developments on future      operating results; |
|--------------------|---------------------------------------------------------------------------------------------------------------|

| ·   | potential      impacts from credit market risk; |
|--------------------|-------------------------------------------------|

| ·   | future      effective income tax rates; |
|--------------------|-----------------------------------------|

| ·   | the      outcome of contingencies; |
|--------------------|------------------------------------|

| ·   | the      availability and cost of raw materials;and |
|--------------------|-----------------------------------------------------|

| ·   | pension      plan assumptions and futurecontributions. |
|--------------------|--------------------------------------------------------|

----

|                        |   | For      the Fiscal Quarters EndedJanuary      31, |    |   | For      the Nine Months EndedJanuary      31, |   |
|-----------------------------|--------|----------------------------------------------------|---------|--------|------------------------------------------------|--------|
| In      thousands           |   | 2009                                               |    |   | 2008                                           |   |   | Percent      Change |   |   | 2009 |   |   | 2008 |   |   | Percent      Change |   |
| Equipment      and software |   | $                                                  | 38,224  |   |                                           | $      | 50,333 |   |   |   | (24.1 | %) |   | $ | 128,125 |   |   | $ | 148,703 |   |   |   | (13.8 | %) |
| Aftermarket      supplies   |   |                                               | 64,289  |   |                                           |   | 83,304 |   |   |   | (22.8 | %) |   |   | 248,989 |   |   |   | 262,319 |   |   |   | (5.1 | %) |
| Service                     |   |                                               | 17,584  |   |                                           |   | 18,329 |   |   |   | (4.1 | %) |   |   | 55,599 |   |   |   | 55,327 |   |   |   | 0.5 | % |
| Total      revenue          |   | $                                                  | 120,097 |   |                                           | $      | 151,966 |   |   |   | (21.0 | %) |   | $ | 432,713 |   |   | $ | 466,349 |   |   |   | (7.2 | %) |

----

|                                    |   | For      the Fiscal QuartersEnded      January 31, |    |   | For      the Nine MonthsEnded      January 31, |   |
|-----------------------------------------|--------|----------------------------------------------------|---------|--------|------------------------------------------------|--------|
| In      thousands                       |   | 2009                                               |    |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Sign      Making and Specialty Graphics |   | $                                                  | 64,702  |   |                                           | $      | 83,995 |   |   | $ | 251,261 |   |   | $ | 260,630 |   |
| Apparel      and Flexible Materials     |   |                                               | 43,009  |   |                                           |   | 52,146 |   |   |   | 137,890 |   |   |   | 153,065 |   |
| Ophthalmic      Lens Processing         |   |                                               | 12,386  |   |                                           |   | 15,825 |   |   |   | 43,562 |   |   |   | 52,654 |   |
| Total      revenue                      |   | $                                                  | 120,097 |   |                                           | $      | 151,966 |   |   | $  | 432,713 |   |   | $  | 466,349 |   |

----

|  In      thousands                                   |   | January      31,2009 |   |   | April      30,2008 |   |
|-----------------------------------------------------------|--------|----------------------|--------|--------|--------------------|--------|
| Backlog:                                                  |   |                 |   |   |               |   |
|    Sign      Making and Specialty Graphics |   | $                    | 2,222  |   |               | $      | 3,462 |   |
|    Apparel      and Flexible Materials     |   |                 | 21,717 |   |               |   | 33,770 |   |
|    Ophthalmic      Lens Processing         |   |                 | 2,100  |   |               |   | 1,440 |   |
| Total      backlog                                        |   | $                    | 26,039 |   |               | $      | 38,672 |   |

|                     | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |    |
|--------------------------|----------------------------------------------------|--------|--------|------------------------------------------------|--------------|
| In      thousands        | 2009                                               |   | 2008   |                                           |         | Percent      Change |   |   | 2009 |   |   | 2008 |   |   | Percent      Change |   |
| Gross      profit        | $                                                  | 35,519 |   | $                                              | 43,453       |   |   |   | (18.3 | %) |   | $ | 121,157 |   |   | $ | 135,310 |   |   |   | (10.5 | %) |
| Gross      profit margin |                                               | 29.6   | %      |                                           | 28.6         | % |   |   |   |   |   |   | 28.0 | % |   |   | 29.0 | % |   |   |   |   |

----

|                                              |   | For      the Fiscal Quarters EndedJanuary      31, |   | For      the Nine Months EndedJanuary      31, |
|---------------------------------------------------|--------|----------------------------------------------------|--------|------------------------------------------------|
| In      thousands                                 |   | 2009                                               |   |                                           | 2008 |   |   | PercentChange |   | 2009 |   |   | 2008 |   |   | PercentChange |
| Selling,      general and administrative expenses |   | $                                                  | 30,193 |                                           |   | $ | 30,691 |   |   |   | (1.6 | %) |   | $ | 96,295 |  (1) |   | $ | 99,022 | (1) |   |   | (2.8 | %) |
| Percentage      of revenue                        |   |                                               | 25.1   | %                                              |   |   | 20.2 | % |   |   |   |   |   |   | 22.3 | % |   |   | 21.2 | % |   |   |   |   |

| (1)   | Gains      of $0.6 million on sales of operating assets are included in SG&A for      the nine months ended January 31, 2009 and gains of $1.0 million on sales      of operating assets are included in SG&A for the nine months ended      January 31, 2008. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                          |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |    |
|-------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------------|
| In      thousands             |   | 2009                                               |   |   | 2008                                           |         |   | PercentChange |   |   | 2009 |   |   | 2008 |   |   | PercentChange |   |
| Research      and development |   | $                                                  | 5,329  |   |                                           | $            | 6,466 |   |   |   | (17.6 | %) |   | $ | 17,331 |   |   | $ | 19,483 |   |   |   | (11.0 | %) |
| Percentage      of revenue    |   |                                               | 4.4    | %      |                                           |         | 4.3 | % |   |   |   |   |   |   | 4.0 | % |   |   | 4.2 | % |   |   |   |   |

----

|                             |   | For      the Fiscal Quarters EndedJanuary      31, |   |    | For      the Nine Months EndedJanuary      31, |   |
|----------------------------------|--------|----------------------------------------------------|--------|---------|------------------------------------------------|--------|
| In      thousands                |   | 2009                                               |   |    | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Other      income (expense), net |   | $                                                  | (2,993 | )  |                                           | $      | (435 | )  |   | $ | (4,058 | )  |   | $ | (1,046 | )  |

|                                                |   | For      the Fiscal Quarters EndedJanuary      31, |   | For      the Nine Months EndedJanuary      31, |   |
|-----------------------------------------------------|--------|----------------------------------------------------|--------|------------------------------------------------|--------|
| In      thousands                                   |   | 2009                                               |   |                                           | 2008   |   |   | PercentChange |   |   | 2009 |   |   | 2008 |   |   | PercentChange |   |
| Interest      expense                               |   | $                                                  | 877    |                                           |   | $ | 1,388 |   |   |   | (36.8 | %) |   | $ | 2,354 |   |   | $ | 3,460 |   |   |   | (32.0 | %) |
| Weighted-average      credit facility interest rate |   |                                               | 4.6    | %                                              |   |   | 9.2 | % |   |   |   |   |   |   | 5.1 | % |   |   | 9.5 | % |   |   |   |   |

|                    |   | For      the Fiscal QuartersEnded      January 31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
|                    |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Effective      tax rate |   |                                               | 42.4   | %      |                                           |   | 31.5 | % |   |   | (306.0 | %) |   |   | 31.7 | % |

----

| Operating      Segment                  | Principal      Business                             |
|-----------------------------------------|-----------------------------------------------------|
| Sign      Making and Specialty Graphics | Gerber      Scientific Products ("GSP") and Spandex |
| Apparel      and Flexible Materials     | Gerber      Technology                              |
| Ophthalmic      Lens Processing         | Gerber      Coburn                                  |

|                          |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands             |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Revenue:                      |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|   GSP               |   | $                                                  | 18,512 |   |                                           | $      | 23,237 |   |   | $ | 70,729 |   |   | $ | 75,018 |   |
|   Spandex           |   |                                               | 46,190 |   |                                           |   | 60,758 |   |   |   | 180,532 |   |   |   | 185,612 |   |
| Segment      revenue          |   | $                                                  | 64,702 |   |                                           | $      | 83,995 |   |   | $ | 251,261 |   |   | $ | 260,630 |   |
|                          |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
| Operating      income:        |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|   GSP               |   | $                                                  | 389    |   |                                           | $      | (502 | ) |   | $ | (234 | ) |   | $ | (71 | ) |
|   Spandex           |   |                                               | 516    |   |                                           |   | 2,589 |   |   |   | 6,432 |   |   |   | 6,610 |   |
| Segment      operating income |   | $                                                  | 905    |   |                                           | $      | 2,087 |   |   | $ | 6,198 |   |   | $ | 6,539 |   |

----

|                          |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands             |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Revenue                       |   | $                                                  | 43,009 |   |                                           | $      | 52,146 |   |   | $ | 137,890 |   |   | $ | 153,065 |   |
| Segment      operating income |   | $                                                  | 2,691  |   |                                           | $      | 5,645 |   |   | $ | 11,340 |   |   | $ | 19,129 |   |

----

|                          |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands             |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Revenue                       |   | $                                                  | 12,386 |   |                                           | $      | 15,825 |   |   | $ | 43,562 |   |   | $ | 52,654 |   |
| Segment      operating income |   | $                                                  | 737    |   |                                           | $      | (340 | ) |   | $ | 2,625 |   |   | $ | 3,039 |   |

|                    |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands       |   | 2009                                               |   |   | 2008                                           |   |   | 2009 |   |   | 2008 |   |
| Operating      expenses |   | $                                                  | 4,336  |   |                                           | $      | 1,096 |   |   | $ | 12,632 |   |   | $ | 11,902 |   |

----

|  In      thousands, except ratio amounts                  |   | January      31,2009 |    |   | April      30,2008 |   |
|----------------------------------------------------------------|--------|----------------------|---------|--------|--------------------|--------|
| Cash      and cash equivalents                                 |   | $                    | 10,940  |   |               | $      | 13,892 |   |
| Working      capital                                           |   | $                    | 92,060  |   |               | $      | 106,005 |   |
| Total      debt                                                |   | $                    | 75,000  |   |               | $      | 42,000 |   |
| Net      debt (total debt less cash and cash equivalents) |   | $                    | 64,060  |   |               | $      | 28,108 |   |
| Shareholders'      equity                                      |   | $                    | 146,762 |   |               | $      | 169,563 |   |
| Total      capital (net debt plus shareholders' equity)        |   | $                    | 210,822 |   |               | $      | 197,671 |   |
| Current      ratio                                             |   | 1.98:1               |    |   | 1.89:1             |   |
| Net      debt-to-total capital ratio                           |   |                 | 30.4    | %      |               |   | 14.2 | % |

|                                                        | For      the Nine Months Ended January 31, |   |
|-------------------------------------------------------------|--------------------------------------------|--------|
| In      thousands                                           |                                       | 2009   |   |   | 2008 |   |
| Cash      flows provided by (used for) operating activities |                                       | $      | 6,318 |   |   | $ | (1,368 | ) |
| Cash      flows used for investing activities               |                                       | $      | (38,559 | ) |   | $ | (11,331 | ) |
| Cash      flows provided by financing activities            |                                       | $      | 32,628 |   |   | $ | 16,057 |   |

----

----

| Total      Funded Debt to Consolidated EBITDA Ratio |   | ABR      Margin(basis      points) |   |   | LIBOR      Margin(basis      points) |   |   | Commitment      Fee (basis points) |   |
|-----------------------------------------------------|--------|------------------------------------|--------|--------|--------------------------------------|--------|--------|------------------------------------|--------|
| 3.00x      and greater                              |   |                               | 300.0  |   |                                 |   | 400.0  |                               |   |   | 50.0 |   |
| 2.25x      to less than 3.00x                       |   |                               | 225.0  |   |                                 |   | 325.0  |                               |   |   | 50.0 |   |
| 1.50x      to less than 2.25x                       |   |                               | 175.0  |   |                                 |   | 275.0  |                               |   |   | 37.5 |   |
| 0.75x      to less than 1.50x                       |   |                               | 137.5  |   |                                 |   | 237.5  |                               |   |   | 25.0 |   |
| Less      than 0.75x                                |   |                               | 100.0  |   |                                 |   | 200.0  |                               |   |   | 25.0 |   |

----

----

----

| Period                                              |   | (a)TotalNumberof      Shares(or      Units)Purchased |   |   | (b)AveragePricePaid      perShare(or      Unit) |   | (c)Total      Number ofShares      (or Units)Purchased      as Partof      PubliclyAnnounced      Plansor      Programs | (d)MaximumNumber      (orApproximateDollar      Value)of      Shares (or Units)that      May Yet BePurchased      Under thePlans      or Program |
|-----------------------------------------------------|--------|------------------------------------------------------|--------|--------|-------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| November      1, 2008 – November 30, 2008     |   |                                                 | ---    |   |                                            |   | ---                                                                                                                     |                                                                                                                                             | Not      applicable | Not      applicable |
| December      1, 2008 – December 31, 2008 (1) |   |                                                 | 3,440  |   |                                            | $      | 2.05                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |
| January      1, 2009 – January 31, 2009 (1)   |   |                                                 | 471    |   |                                            |   | 5.11                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |
|                                                |   |                                                 | 3,911  |   |                                            | $      | 2.42                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |

----

| Total      Funded Debt to Consolidated EBITDA Ratio |   | ABR      Margin(basis      points) |   |   | LIBOR      Margin(basis      points) |   |   | Commitment      Fee (basis points) |   |
|-----------------------------------------------------|--------|------------------------------------|--------|--------|--------------------------------------|--------|--------|------------------------------------|--------|
| 3.00x      and greater                              |   |                               | 300.0  |   |                                 |   | 400.0  |                               |   |   | 50.0 |   |
| 2.25x      to less than 3.00x                       |   |                               | 225.0  |   |                                 |   | 325.0  |                               |   |   | 50.0 |   |
| 1.50x      to less than 2.25x                       |   |                               | 175.0  |   |                                 |   | 275.0  |                               |   |   | 37.5 |   |
| 0.75x      to less than 1.50x                       |   |                               | 137.5  |   |                                 |   | 237.5  |                               |   |   | 25.0 |   |
| Less      than 0.75x                                |   |                               | 100.0  |   |                                 |   | 200.0  |                               |   |   | 25.0 |   |

| Exhibit      Number |   | Description |
|---------------------|--------|-------------|
|                |   |        |
|                | 31.1   |        | Certification      of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|                |   |        |   |
|                | 31.2   |        | Certification      of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|                |   |        |   |
|                | 32     |        | Certification      of Chief Executive Officer and Chief Financial Officer pursuant to Rule      13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18      U.S.C. 1350, filed herewith. |

----

|               | GERBER      SCIENTIFIC, INC.                                                                                                                                         |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| March      9, 2009 | By:                                                                                                                                                                  |       /s/    John      J.  Krawczynski       |
|               |  John J.      KrawczynskiVice      President, Chief Accounting Officer and Corporate Controller(Duly      Authorized Officer and Principal Accounting  Officer) |

----

Exhibit Index

| Exhibit Number |   | Description |
|----------------|--------|-------------|
|           |   |        |
|           | 31.1   |        | Certification      of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|           |   |        |   |
|           | 31.2   |        | Certification      of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|           |   |        |   |
|           | 32     |        | Certification      of Chief Executive Officer and Chief Financial Officer pursuant to Rule      13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18      U.S.C. 1350, filed herewith. |

----